Research output per year
Research output per year
- 11 results
Search results
-
2023
A precision medicine tool for high utilization and quality of individual treatment trials with immunomodulatory drugs in mucopolysaccharidosis
Wiesinger, A., Bigger, B., Lampe, C., Giugliani, R., Kampmann, C., Moser, T., Scarpa, M. & Lagler, F., 2023, In: MOLECULAR GENETICS AND METABOLISM . 138, 2, p. 135-136Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value
Moser, T. (First author) & Seiberl, M. (Last author), 25 Apr 2023, In: NEUROLOGY . 100, 17, 2 p., 2694.Research output: Contribution to journal › Abstract (Journal) › peer-review
1 Citation (Web of Science) -
2022
Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications
Moser, T., Otto, F., Pilz, G. & Wipfler, P., 2022, In: EUROPEAN JOURNAL OF NEUROLOGY. 29, p. 395-395Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2021
Extensive Long-term Immune Cell Profiling Reveals Further Targets of Oral Cladribine in MS
Moser, T., Ziemssen, T. & Sellner, J., 2021, In: NEUROLOGY . 96, 15Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2019
Chronic inflammatory demyelinating polyneuropathy with anti-contactin-1 antibody: a case report
Poppert, K., Kleindienst, W., Rosler, C., Neuray, C., Kunz, A., Leitinger, M., Moser, T., Grinzinger, S., Hoftberger, R. & Sellner, J., 2019, In: EUROPEAN JOURNAL OF NEUROLOGY. 26, p. 900-900Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Coexpression analysis of alpha-4 and beta-1 reveals VLA4-related subset heterogeneity and the VLA4(hi) phenotype associated with JCV seropositivity
Harrer, A., Frommrich, M., Moser, T., Federspieler, A., Wipfler, P., Afazel, S., Kraus, J., Haschke-Becher, E. & Sellner, J., 2019, In: MULTIPLE SCLEROSIS . 25, p. 447-447Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Initial real-life experience with ocrelizumab in patients with relapsing-remitting and primary progressive multiple sclerosis in Salzburg, Austria
Feige, J., Moser, T., Nagy, Z., Otto, F., Wipfler, P., Trinka, E. & Sellner, J., 2019, In: EUROPEAN JOURNAL OF NEUROLOGY. 26, p. 489-489Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Neuroborreliosis with cranial polyradiculitis and progressive brain stem infarction in a Crohnxxxs disease patient with anti-tumor necrosis factor-alpha therapy
Moser, T., Bubel, N., Pikija, S., Machegger, L. & Sellner, J., 2019, In: EUROPEAN JOURNAL OF NEUROLOGY. 26, p. 822-822Research output: Contribution to journal › Abstract (Journal) › peer-review
-
2017
Natalizumab-related progressive multifocal leukoencephalopathy in Austria: An observational nationwide study
Moser, T., Fertl, E., Koppi, S., Seifert-Held, T., Safoschnik, G., Bsteh, G., Heller, T., Rommer, P., Baumgartner, A., Berger, T. & Sellner, J., 2017, In: EUROPEAN JOURNAL OF NEUROLOGY. 24, p. 38-38Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Risk factors for intensive care unit admission in patients with autoimmune encephalitis
Harutyunyan, G., Pikija, S., Moser, T., Dunser, M., Leitinger, M., Novak, H., Aichhorn, W., Trinka, E., Hauer, L. & Sellner, J., 2017, In: EUROPEAN JOURNAL OF NEUROLOGY. 24, p. 19-20Research output: Contribution to journal › Abstract (Journal) › peer-review
-
The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab
Harrer, A., Frommrich, M., Moser, T., Afazel, S., Haschke-Becher, E., Wipfler, P. & Sellner, J., 2017, In: MULTIPLE SCLEROSIS . 23, p. 337-338Research output: Contribution to journal › Abstract (Journal) › peer-review